141 related articles for article (PubMed ID: 217692)
1. Lecithin: cholestrol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type IIa hyperlipoproteinaemia.
Wallentin L
Eur J Clin Invest; 1978 Dec; 8(6):383-9. PubMed ID: 217692
[No Abstract] [Full Text] [Related]
2. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
3. Dietary and drug treatment of primary hyperlipoproteinemia.
Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
[No Abstract] [Full Text] [Related]
4. The effect of cholestyramine on lipoprotein lipids in patients with primary type IIA hyperlipoproteinemia.
Weisweiler P; Neureuther G; Schwandt P
Atherosclerosis; 1979 Jul; 33(3):295-300. PubMed ID: 226105
[TBL] [Abstract][Full Text] [Related]
5. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
Mann JI; Harding PA; Turner RC; Wilkinson RH
Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
[TBL] [Abstract][Full Text] [Related]
6. The pediatrician's role in genetic hyperlipidemias.
Schleman MM
Del Med J; 1981 Sep; 53(9):473-4. PubMed ID: 7338289
[No Abstract] [Full Text] [Related]
7. Acute effects of cholestyramine on serum lipoprotein concentrations in type II hyperlipoproteinaemia.
Olsson AG; Dairou F
Atherosclerosis; 1978 Jan; 29(1):53-61. PubMed ID: 204317
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipoproteins and hyperlipoproteinemia.
Gustafson A; Berg K
Acta Med Scand; 1973 May; 193(5):369-72. PubMed ID: 4352670
[No Abstract] [Full Text] [Related]
9. Effects of diet and type IIa hyperlipoproteinemia upon structure of triacylglycerols and phosphatidyl cholines from human plasma lipoproteins.
Gordon DT; Pitas RE; Jensen RG
Lipids; 1975 May; 10(5):270-83. PubMed ID: 165345
[TBL] [Abstract][Full Text] [Related]
10. Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK
Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
[No Abstract] [Full Text] [Related]
11. [Type II primary hyperlipoproteinemia: effect of dietary treatment and cholestyramine on serum lipids and lipoproteins].
Vaverková H; Kubasta M; Zmeskal A; Procházka J; Vrublowský P; Podivínský
Vnitr Lek; 1976 Jan; 22(1):73-83. PubMed ID: 175564
[No Abstract] [Full Text] [Related]
12. Diet and drug treatment of hyperlipidemia and atherosclerosis.
Kuo PT
Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
[No Abstract] [Full Text] [Related]
13. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
14. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects.
Wallentin L; Angelin B; Einarsson K; Leijd B
Scand J Clin Lab Invest Suppl; 1978; 150():103-10. PubMed ID: 218268
[No Abstract] [Full Text] [Related]
15. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
16. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Carlson LA; Olsson G; Ballantyne D
Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526
[TBL] [Abstract][Full Text] [Related]
17. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
Angelin B; Einarsson K
Atherosclerosis; 1981; 38(1-2):33-8. PubMed ID: 7470203
[TBL] [Abstract][Full Text] [Related]
18. The effect of soya lecithin on serum lipid values in type II hyperlipoproteinemia.
ter Welle HF; van Gent CM; Dekker W; Willebrands AF
Acta Med Scand; 1974 Apr; 195(4):267-71. PubMed ID: 4362483
[No Abstract] [Full Text] [Related]
19. Studies on the pharmacological control of hyperlipemia in experimental nephrotic syndrome.
Edwards KD; Usardi MM; Galli C; Paoletti R
Biochem Pharmacol; 1970 Oct; 19(10):2719-25. PubMed ID: 5478582
[No Abstract] [Full Text] [Related]
20. Achilles tendinitis and tenosynovitis. A diagnostic manifestation of familial type II hyperlipoproteinemia in children.
Shapiro JR; Fallat RW; Tsang RC; Glueck CJ
Am J Dis Child; 1974 Oct; 128(4):486-90. PubMed ID: 4369742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
